Publications

Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study  (2024)

Authors:
Franchi, Carlotta; Rossio, Raffaella; Mandelli, Sara; Ardoino, Ilaria; Nobili, Alessandro; Peyvandi, Flora; Mannucci, Pier Mannuccio; Reposi, Investigators; Girelli, Domenico; Minuz, Pietro
Title:
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study
Year:
2024
Type of item:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Language:
Inglese
Referee:
No
Name of journal:
INTERNAL AND EMERGENCY MEDICINE
ISSN of journal:
1828-0447
N° Volume:
19
Number or Folder:
3
Page numbers:
689-696
Keyword:
ACE inhibitors; ARBs; Older people; Pneumonia; Statins
Short description of contents:
The aims of this study is to evaluate the association between angiotensin-converting enzyme inhibitor (ACE-I), angiotensin II receptor blocker (ARBs) and/or statin use with the risk of pneumonia, as well as and with in-hospital and short-term outpatient mortality in hospitalized older patients with pneumonia. Patients aged 65 years or older hospitalized in internal medicine and/or geriatric wards throughout Italy and enrolled in the REPOSI (REgistro Politerapuie SIMI-Societa Italiana di Medicina Interna) register from 2010 to 2019 were screened to assess the diagnosis of pneumonia and classified on whether or not they were prescribed with at least one drug among ACE-I, ARBs, and/or statins. Further study outcomes were mortality during hospital stay and at 3 months after hospital discharge. Among 5717 cases included (of whom 18.0% with pneumonia), 2915 (51.0%) were prescribed at least one drug among ACE-I, ARBs, and statins. An inverse association was found between treatment with ACE-I or ARBs and pneumonia (OR = 0.79, 95% CI 0.65-0.95). A higher effect was found among patients treated with ACE-I or ARBs in combination with statins (OR = 0.67, 95% CI 0.52-0.85). This study confirmed in the real-world setting that these largely used medications may reduce the risk of pneumonia in older people, who chronically take them for cardiovascular conditions.
Note:
REPOSI collaborators are listed in the Supplementary appendix 1
Web page:
https://link.springer.com/article/10.1007/s11739-023-03528-w
Product ID:
139588
Handle IRIS:
11562/1126258
Last Modified:
October 5, 2024
Bibliographic citation:
Franchi, Carlotta; Rossio, Raffaella; Mandelli, Sara; Ardoino, Ilaria; Nobili, Alessandro; Peyvandi, Flora; Mannucci, Pier Mannuccio; Reposi, Investigators; Girelli, Domenico; Minuz, Pietro, Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study «INTERNAL AND EMERGENCY MEDICINE» , vol. 19 , n. 32024pp. 689-696

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

<<back

Activities

Research facilities

Share